Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Daly

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Breast Cancer Research and Treatment|January 11, 2015
Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family RegistryTú Nguyen-Dumont, Fleur Hammet, Maryam Mahmoodi, et al.
The Journal of Pediatrics|July 1, 2022
Mother and Daughter Perspectives on Genetic Counseling and Testing of Adolescents for Hereditary Breast Cancer RiskCatherine Jennings, Julia Wynn, Cecilia Miguel, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|May 22, 2014
Human subjects protection: an event monitoring committee for research studies of girls from breast cancer familiesDiana Harris, Linda Patrick-Miller, Lisa Schwartz, et al.
The Journal of Infection|January 14, 2021
A multicentre analysis of Clostridium difficile in persons with Cystic Fibrosis demonstrates that carriage may be transient and highly variable with respect to strain and levelJennifer Deane, Fiona Fouhy, Nicola J Ronan, et al.
International Journal of Cancer|December 7, 2005
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an updateJacek Gronwald, Nadine Tung, William D Foulkes, et al.
Journal of the National Cancer Institute|September 25, 2008
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriersAndrea Eisen, Jan Lubinski, Jacek Gronwald, et al.
Human Genetics|January 29, 2013
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutationErica S Rinella, Yongzhao Shao, Lauren Yackowski, et al.
Breast Cancer Research and Treatment|May 16, 2017
Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome predictionMolly Scannell Bryan, Maria Argos, Irene L Andrulis, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutationsAlfonso Bellacosa, Andrew K Godwin, Suraj Peri, et al.
JAMA Network Open|August 26, 2024
Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial RiskJasmine A McDonald, Yuyan Liao, Julia A Knight, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Breast Cancer Research and Treatment|January 11, 2015
Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family RegistryTú Nguyen-Dumont, Fleur Hammet, Maryam Mahmoodi, et al.
The Journal of Pediatrics|July 1, 2022
Mother and Daughter Perspectives on Genetic Counseling and Testing of Adolescents for Hereditary Breast Cancer RiskCatherine Jennings, Julia Wynn, Cecilia Miguel, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|May 22, 2014
Human subjects protection: an event monitoring committee for research studies of girls from breast cancer familiesDiana Harris, Linda Patrick-Miller, Lisa Schwartz, et al.
The Journal of Infection|January 14, 2021
A multicentre analysis of Clostridium difficile in persons with Cystic Fibrosis demonstrates that carriage may be transient and highly variable with respect to strain and levelJennifer Deane, Fiona Fouhy, Nicola J Ronan, et al.
International Journal of Cancer|December 7, 2005
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an updateJacek Gronwald, Nadine Tung, William D Foulkes, et al.
Journal of the National Cancer Institute|September 25, 2008
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriersAndrea Eisen, Jan Lubinski, Jacek Gronwald, et al.
Human Genetics|January 29, 2013
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutationErica S Rinella, Yongzhao Shao, Lauren Yackowski, et al.
Breast Cancer Research and Treatment|May 16, 2017
Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome predictionMolly Scannell Bryan, Maria Argos, Irene L Andrulis, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutationsAlfonso Bellacosa, Andrew K Godwin, Suraj Peri, et al.
JAMA Network Open|August 26, 2024
Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial RiskJasmine A McDonald, Yuyan Liao, Julia A Knight, et al.
Pageof 8